{"name":"Barry Borlaug","slug":"barry-borlaug","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9JVjlaYURuT3RrTno4REJNaE00YnJGVG84ZVlQTDRTVmRGbWxOSFVfSzByckpFTzI2VHVSYWVvUlljbnY1THpONGtVbmtGZ3lpMl9hbVpvWHRSN3ItbzdB?oc=5","date":"2025-08-31","type":"trial","source":"Nature","summary":"Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trial - Nature","headline":"Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNMWVubUU1a3EwV3lxdFJkbkRIdDF6ZFM1Unh0cHN5Y0p0Y081em1GSWFQV0FnTDk2SXVHUXF1LWt6dHdzYXA3Q3FXUU1kb2E5R05hbnExb2dNdmpCNzQybmpmS3lkMnZaS1VkWGZOQnJraEJ5c01lVk9iQnBqR3pLNFVVU1V3dWZEeHUw?oc=5","date":"2025-02-12","type":"pipeline","source":"TCTMD.com","summary":"Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity - TCTMD.com","headline":"Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE44eUFrYS1iOUpHSXlmSnIyS2RvZTE0R2pqNThLT2VsTDcxUGpPVDZtc1BTMXFqN0tfZ2I4Zkh4eW5zWjVLVkV1Y2tITzVJeWFaNnRabXVkVWl1dG9Nb2ZzcEk2eC1IV0lfQU9PQkJSVmxXSmtpOGdFRw?oc=5","date":"2025-01-22","type":"pipeline","source":"American Heart Association Journals","summary":"Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting | Circulation - American Heart Assoc","headline":"Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFB2Um9XTlJoRGJXbV9yb19CeWdXZ0R5WWtmVkVYQ1VtUFY2cC1sRHpNWWVnczBhRU9YZW45VjNHcS1aSnZrV0YxVXQwNmtOcDdWd1dkbXc3TGtxbFNTOHhn?oc=5","date":"2024-11-17","type":"trial","source":"Nature","summary":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial - Nature","headline":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction an","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5vLXF5TVRlSFBUZDdveExScFByRUZKamJIWk4zMlZ4NUlVbjZIV0tkN0hobDlFQ1hkRFFIWW84VFdINGFpX2JpN0pWRmJ3OWMxcVQ1T2pRdnVMS0Q1YkZr?oc=5","date":"2023-08-27","type":"regulatory","source":"Nature","summary":"Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial - Nature","headline":"Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9taGlEdUxDNHdLRTdPaW9xZ2VMUDA0QkdrV2ZZRnpwNmtsaFJrRW0zMlRkMXhNNEhKTWZPbC12bVE2UXlsYXlmNmZxNVNVc1pZNG9kLWNDaGlOd3QzRTNra0hFZzdEV2NGZGMwWGpSUVFLMTdMQ2NsVC1rUXlKWkE?oc=5","date":"2023-03-05","type":"pipeline","source":"TCTMD.com","summary":"RAPID-HF: Rate-Adaptive Pacing Doesn’t Help in HFpEF - TCTMD.com","headline":"RAPID-HF: Rate-Adaptive Pacing Doesn’t Help in HFpEF","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE1qWV9INHhyZWs2MUZQOHB4N0xMX0MwRE1pODN5eHdwUE1vTm1iNnZXdEVrLWJYbnR1dlZlWXVuajhJZ2pPdUVMd2VLckFia2hNZFpzUE9vbmtYM3Y2bWx2cUhTaGZpa3hyUXFRdmNmSnRzLW8?oc=5","date":"2022-03-31","type":"trial","source":"American Heart Association Journals","summary":"Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure - American Heart Association Journals","headline":"Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTFByY2tIQnRCU0lEZXdQLTY5NFB4WXREWWdSdk9CR0tEQWJxVkFMX20xYlJvRnF0Wk5kNTZfdjd3Y2Y1Wm9KTVRPTXhGMHpvMHN6WW9YekdkUk94bHRGQ2diclNfeERqRzVleWg5NXl0b3J0WDA?oc=5","date":"2020-03-23","type":"pipeline","source":"American Heart Association Journals","summary":"Research Priorities for Heart Failure With Preserved Ejection Fraction | Circulation - American Heart Association Journals","headline":"Research Priorities for Heart Failure With Preserved Ejection Fraction | Circulation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPSGwxQTg0R3JIS1ZRcWZld202RnZpdk5NcURVSjdpNnJhMWJSNUh0cS13cncxVlpkVktrc1p4MjFGcHphNDJId0hkWElCaGFuSjNQVWsxaTNucWx5ejg4RmxjV2tKbzBjR3hfdGlvQTdIMGNwS3FhRDBUY1VXU0xKYktxR1NydFljeFBFNTdvS3RfRVRuVHFUb001MFRrZw?oc=5","date":"2018-03-12","type":"deal","source":"Fierce Biotech","summary":"Savara abandons drug behind last year’s reverse merger with Mast - Fierce Biotech","headline":"Savara abandons drug behind last year’s reverse merger with Mast","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}